InsiderTrades

Form 4 for RCKT ROCKET PHARMACEUTICALS, INC.

Accepted 2026-07-06 20:00:01 ET · period of report 2026-06-18 · accession 0001140361-26-027681 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2026-07-06 20:00 2026-06-18 RCKT WONG RODERICK Dir, 10% A - Grant $0.00 +27.8K 75.5K +58% $0
D 2026-07-06 20:00 2026-06-18 RCKT WONG RODERICK Dir, 10% A - Grant $0.00 +79.0K 79.0K New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2026-06-18 A A 27,832 $0.00 75,499 D — — (F1) Represents restricted stock units ("RSUs") that convert to common stock on a one-for-one basis. The RSUs will vest in full on June 18, 2027. (F1) Represents restricted stock units ("RSUs") that convert to common stock on a one-for-one basis. The RSUs will vest in full on June 18, 2027. (F1) Represents restricted stock units ("RSUs") that convert to common stock on a one-for-one basis. The RSUs will vest in full on June 18, 2027. (F1) Represents restricted stock units ("RSUs") that convert to common stock on a one-for-one basis. The RSUs will vest in full on June 18, 2027.
2 Derivative Stock Option (Right to Buy) 2026-06-18 A A 78,960 $0.00 78,960 D $3.35 · — to 2036-06-18 78,960 Common Stock (F3) This option represents a right to purchase a total of 78,960 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on June 18, 2027.